Validity of resting strain/strain rate in prediction of myocardial viability

Amr Hanafy1, Soliman Ghareb Ibrahim2, Hossam-Eldein Mohamed Mohamed Mansour3

  • 1Cardiovascular Department, Aswan University, Aswân, Egypt. Amrhanafy75@yahoo.com.

Insights

Resting strain and strain rate measurements from echocardiography accurately predict myocardial viability after heart attack. These non-invasive measures show promise for assessing heart muscle health post-myocardial infarction.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Assessing myocardial viability after acute myocardial infarction (AMI) is crucial for guiding treatment decisions.
  • Delayed enhancement cardiac magnetic resonance imaging (DE-CMR) is the gold standard but is costly and not widely accessible.
  • Non-invasive echocardiography offers a potential alternative for evaluating myocardial viability.

Purpose of the Study:

  • To determine if resting strain and strain rate measurements from echocardiography can accurately predict myocardial viability.
  • To compare echocardiographic findings with DE-CMR in patients post-AMI.

Main Methods:

  • Sixty patients, three months post-AMI, underwent resting echocardiography with offline deformation index analysis.
  • Gadolinium contrast-enhanced cardiac magnetic resonance imaging (DE-CMR) was performed as the gold standard.
  • 268 myocardial segments with resting wall motion abnormalities were analyzed.

Main Results:

  • Resting longitudinal strain was significantly higher in viable segments compared to non-viable segments (p < 0.05).
  • Resting longitudinal strain rate was also significantly higher in viable segments for most myocardial regions (p < 0.05).
  • Specific segments showed non-significant differences in strain rate, but overall trends supported viability prediction.

Conclusions:

  • Resting strain and strain rate measurements are accurate predictors of myocardial viability post-AMI.
  • Echocardiography offers a valuable, accessible tool for assessing myocardial viability, complementing DE-CMR.